TechNavio's analysts forecast the Global DNA Sequencing Products market to grow at a CAGR of 18.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witnessing an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market.
TechNavio's report, the Global DNA Sequencing Products Market 2012-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global DNA Sequencing Products market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., and Pacific Biosciences of California Inc.
The other vendors mentioned in the report are Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., and RainDance Technologies Inc.
Key questions answered in this report:
Make an enquiry before buying this Report
Please fill the enquiry form below.
Alpha-fetoprotein (AFP) is the most widely found plasma protein in human fetus. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. It is a major plasma protein which is produced during fetal development in yolk sac and the liver. AFP is a glycoprotein which is found in monomeric, dimeric and trimeric forms. The protein is normally made by immature liver cells in the fetus therefore; inf...
Histone deacetylase (HDAC) are enzymes which remove acetyl groups from an N-acetyl lysine amino acid present on a histone, thus wrapping the DNA tightly by the histones. Histone deacetylase inhibitors (HDIs) are compounds which interfere with this function of histone deacetylase. HDIs display promising potential in oncology for applications such as diagnosis, cancer detection and prognosis. HDIs are emerging class of oncology therapeutics for the...
Biological therapies for cancer include the usage of body’s immune system to curb cancer and to fight the side effects generated out of some other chemotherapeutic treatments. The human body has biological response modifiers (BRMs) that stimulate the body’s response towards an infection. Scientists are now involved in producing such biological response modifiers artificially in laboratories to use them in triggering an immune ...